Search Results 1491-1500 of 19422 for hemoglobin

1. LS138D, Rituximab With or Without Yttrium Y-90 Ibritumomab Tiuxetan in Treating Patients With Untreated Follicular Lymphoma - Mayo Clinic

   Hemoglobin > 10.0 g/dL; Total bilirubin ≤ 1.5 x upper limit of normal (ULN) or if total bilirubin is > 1.5 x ULN, the direct bilirubin must be ≤ ULN ...

2. Myelodysplastic syndromes - Diagnosis and treatment - Mayo Clinic

   Learn how medications and bone marrow transplants are used to control complications caused by these syndromes that affect the bone marrow.

3. Filgotinib in the Induction and Maintenance of Remission in Adults With Moderately to Severely Active Crohn's Disease - Mayo Clinic

   Hemoglobin ≥ 8 g/dL (both males and females);; Absolute neutrophil count (ANC) ≥1.5 × 10^9/L (1,500/mm^3);; Platelets ≥ 100 × 10^9/L;; White blood cells ...

4. A Study to Evaluate Estetrol to Treat Moderate-to-Severe Vasomotor Symptoms in Postmenopausal Women - Mayo Clinic

   ... hemoglobin above 7%; 9. Dyslipoproteinaemia (LDL >190 mg/dL and triglycerides >300 mg/dL); 10. Smoking: 1. Efficacy Study part: subjects smoking >5 ...

5. Combination Chemotherapy, Radiation Therapy, and an Autologous Peripheral Blood Stem Cell Transplant in Treating Young Patients with Atypical Teratoid/Rhabdoid Tumor of the Central Nervous System - Mayo Clinic

   Hemoglobin > 8 g/dL (RBC transfusions allowed); Creatinine clearance (minimum of 12-24 hour urine collection) or radioisotope GFR ≥ 60mL/min; Total bilirubin ...

6. Glipizide (oral route) - Mayo Clinic

   Glipizide belongs to a class of drugs called sulfonylureas. It stimulates the release of insulin from the pancreas, directing your body to store blood sugar.

7. A Study of Ibrutinib as Prophylaxis for Chronic Graft-Versus-Host Disease (GVHD) in Patients Undergoing Allogeneic Hematopoietic Cell Transplantation (allo-HCT) - Mayo Clinic

   Karnofsky Performance Status (PS) ≥ 70. The following laboratory values obtained ≤ 7 days prior to registration: Hemoglobin ≥ 8.0 g/dL (*Untransfused); ...

8. A Study of MT-5111 in HER2-positive Solid Tumors - Mayo Clinic

   Hemoglobin ≥ 8.0 g/dL. Red blood cell transfusion within 2 wk of study treatment start is allowed if hemoglobin levels remain stable (i.e., do not decrease ...

9. Pharmacokinetic and Safety Study of Nab ®-Paclitaxel (ABI-007) Plus Gemcitabine in Subjects with Advanced Pancreatic Cancer Who Have Cholestatic Hyperbilirubenemia - Mayo Clinic

   Hemoglobin (Hgb) ≥ 9 g/dL. Subject has the following blood chemistry levels at screening (obtained ≤ 14 days prior to starting Cycle 1 Day 1):. AST (SGOT) ...

10. Publications - Leslie J. Padrnos, M.D. - Mayo Clinic

    ... hemoglobin Evans with secondary methemoglobinemia. J Clin Apher. 2023 Dec; 38 (6):755-759 Epub 2023 Sept 04. View PubMed; Riaz IB, Fuentes H, Deng Y, Naqvi ...